Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.23629 | 9 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.16468 | 7 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.17542 | 8 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.11883 | 7 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.1147 | 7 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.24191 | 8 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.24297 | 9 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.14555 | 7 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.1295 | 7 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.18536 | 8 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.1598 | 8 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.14337 | 7 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.16598 | 7 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.16549 | 8 |